Trump: 6-Week Abortion Ban a 'Mistake'; Capitol Doc Scrutiny; Immigrant Health Costs

— Health news and commentary from around the Web gathered by MedPage Today staff

MedpageToday
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require registration or subscription.

Former president Donald Trump called 6-week bans on abortion a "terrible mistake." (NBC News)

Meanwhile, former vice president Mike Pence said he hasn't decided whether to get the updated COVID shot. (The Hill)

The Biden administration plans to penalize insurers $100 per policyholder per day for shirking mental health parity laws. (Politico)

Capitol physician Brian Monahan, MD, has come under scrutiny after citing dehydration as a potential cause of Senate Minority Leader Mitch McConnell's (R-Ky.) recent medical episodes. (New York Times)

For decades, pharmacists told the FDA that the decongestant phenylephrine doesn't work in oral cold medicines; why did it take the agency so long to act? (New York Times)

Enrollment has started in a universal flu vaccine clinical trial, the NIH announced.

Randomized trials for transgender medicine are ethically problematic, researchers say. (STAT)

Pfizer's COVID vaccine reduced ambulatory care visits related to the virus in kids under 5 years of age, a study in JAMA showed.

Total healthcare costs for working-age immigrant adults were less than half that of U.S.-born adults, new data suggest. (JAMA Network Open)

Medication errors related to pediatric attention-deficit/hyperactivity disorder (ADHD) prescriptions have tripled over the past two decades. (Pediatrics)

The FDA sent a slew of warning letters to online retailers along with manufacturers and/or distributors over unauthorized "youth-appealing" e-cigarette products.

And the agency released new draft recommendations saying that interchangeable biosimilars will no longer be required to call out their interchangeable designation on their labels, as "it will not likely be useful to prescribers."

Dana-Farber Cancer Institute announced plans to partner with Beth Israel Deaconess Medical Center in launching a new cancer hospital in Boston, effectively ending its partnership with Brigham and Women's Hospital when the time comes. (WCVB5)

Johnson & Johnson is under investigation in South Africa over the "excessive" price of bedaquiline (Sirturo), a critical tuberculosis (TB) medication. (AP)

Conflict and climate change are stymieing the global effort to end AIDS, TB, and malaria by 2030. (Reuters)

Meanwhile, the odds of ending polio transmission by the end of the year are also not looking good, according to a report from the Global Polio Eradication Initiative. (STAT)

  • author['full_name']

    Shannon Firth has been reporting on health policy as MedPage Today's Washington correspondent since 2014. She is also a member of the site's Enterprise & Investigative Reporting team. Follow